You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動丨片仔癀(600436.SH)反彈4.75% 此前四日累跌逾26% LDS片獲批進行臨牀試驗
格隆匯 07-28 14:39
格隆匯7月28日丨片仔癀上週公吿稱,控股股東漳州市九龍江集團因自身資金需求,擬減持不超過603.3萬股公司股票,佔公司股份1%。這是控股股東自公司上市以來首次披露減持計劃,該公吿披露後,片仔癀股價在二級市場持續降温,在今天之前的四個交易日,股價已經累計跌去逾26%。片仔癀(600436.SH)反彈4.75%今日終於迎來反彈,現漲4.75%,報378.13元,總市值2281億元。片仔癀昨日盤後公佈,公司與上海璃道醫藥科技有限公司合作研發項目LDS片,收到國家藥品監督管理局簽發的《藥物臨牀試驗批准通知書》,LDS片主要用於治療纖維肌痛。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account